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Dysregulation of Connexin (Cx) expression and function is associated with a range of chronic 16 
inflammatory conditions including psoriasis and non-healing wounds. To mimic a pro-17 
inflammatory environment, HaCaT cells, a model human keratinocyte cell line, were 18 
challenged with 10 µg/mL peptidoglycan (PGN) isolated from Staphylococcus aureus for 15 19 
minutes to 24 hours in the presence or absence of connexin blockers and/or following CX26, 20 
CX43, PANX1 and TLR2 siRNA knock-down (KD). Expression levels of IL-6, IL-8, CX26, 21 
CX43, PANX1, TLR2 and Ki67 were assessed by RT-qPCR, western blot and/or 22 
immunocytochemistry. NF-kβ was blocked with BAY11-7082, CX-channel function was 23 
determined by ATP release assays. ELISA monitored IL6 release following PGN challenge in 24 
the presence or absence of siRNA or blockers of connexin or purinergic signalling. Exposure 25 
to PGN induced IL-6, IL-8, CX26 and TLR2 gene expression but it did not influence CX43, 26 
PANX1 or Ki67 mRNA expression levels. CX43 protein levels were reduced following 24 h 27 
PGN exposure. PGN-induced CX26 and IL-6 expression were also aborted by TLR2-KD and 28 
inhibition of NF-kβ. ATP and IL-6 release were stimulated following 15 min and 1-24 h 29 
challenge with PGN respectively. Release of both agents was inhibited by co-incubation with 30 
Cx-channel blockers, CX26-, CX43- and TLR2-KD. The IL-6 response was also reduced by 31 
purinergic blockers. CX-signalling plays a role in the innate immune response in the epidermis. 32 
PGN is detected by TLR2, which via NF-kβ, directly activates CX26 and IL-6 expression. 33 
CX43 and CX26 maintain pro-inflammatory signalling by permitting ATP release, however 34 
PANX1 does not participate.  35 
 36 
Keywords: Connexin 26, Connexin 43, Pannexin 1, Peptidoglycan, Toll-Like-Repector2, NF-37 
kB, purinergic signalling, epidermis, inflammation, intercellular signalling. 38 
  39 
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1. INTRODUCTION 40 
The skin forms a physical barrier between the organism and the external environment, 41 
protecting from physical, chemical or biological aggression (Baroni et al., 2012). The 42 
epidermis, the outer layer of the skin, is principally composed of keratinocytes that are 43 
subclassified into four layers: the basal, spinous, granular and cornified layers. From the basal 44 
layer keratinocytes proliferate and differentiate moving throughout the layers until the cornified 45 
layer. The epidermis is avascular so the delivery and co-ordination of intercellular signals 46 
directly between the cell layers is believed to be directed via gap junction intercellular channels 47 
(Martin et al., 2014). Connexins (Cx), the structural building blocks of gap junctions, are a 48 
family of 21 different proteins in humans. Up to ten connexins are differentially expressed 49 
throughout the stratified epidermis, suggesting a key role in differentiation and maintenance of 50 
epidermal integrity (Di et al., 2001). Six connexins oligomerise to form a hemichannel, that is 51 
trafficked in a closed state, to the plasma membrane where it aligns and docks with a 52 
hemichannel from a neighbouring cell to form a gap junction intercellular channel permitting 53 
the interchange of small molecules (<1.2kDa) (Laird, 2006). Under conditions of cell stress 54 
connexin hemichannels within the membrane can be induced to open rendering the cell 55 
susceptible to release of ATP ‘danger- signals’ with subsequent effects on downstream 56 
purinergic signalling pathways (Ceelen et al., 2011). Two predominant connexins in human 57 
epidermis CX43 (encoded by the α gene family member, GJA1) and CX26 (encoded by the β 58 
gene family member GJB2) are unable to form heteromeric channels and have distinctive 59 
permeability properties, suggesting specialised spatial communication compartments exist 60 
within the epidermis (Chanson et al., 2018; Kam et al., 1986). Pannexins (Panx) share structural 61 
but not amino acid sequence homology with connexins and also form channels releasing ATP 62 
and other signalling molecules into the extracellular milieu. Three isoforms have been 63 
identified and two of them are expressed in the skin (Panx3 and mainly PANX1) (Celetti et al., 64 
2010). 65 
Several congenital skin disorders characterised by abnormal keratinisation and hypertrophy are 66 
associated with dominant mutations in β-connexin genes and they fall into two main classes 67 
(Martin and van Steensel, 2015). Firstly, those with loss of channel function and defective 68 
trafficking such as CX26-D66H, associated with Vohwinkel syndrome (OMIM#124500), a 69 
hyperproliferative but non-inflammatory skin disorder. Secondly, those CX26 mutations linked 70 
with inflammatory disorders such as keratitis ichthyosis deafness syndrome (KID) 71 
(OMIM#148210) which is proposed to be caused by ‘leaky’ hemichannels and is characterised 72 
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by the susceptibility of patients to severe bacterial and fungal skin infections (Garcia et al., 73 
2016; Martin and van Steensel, 2015). Recent reports also suggest that these mutations in CX26 74 
alter CX26:CX43 compatibility giving rise to differential signalling properties (Shuja et al., 75 
2016). Deregulation of CX26 and CX43 are also associated with other inflammatory and 76 
hyperproliferative skin conditions including chronic non-healing wounds (Brandner et al., 77 
2004; Sutcliffe et al., 2015) and psoriasis, where increased CX26 expression is a hallmark of 78 
the condition (Labarthe et al., 1998; Li et al., 2014; Lucke et al., 1999). In addition, psoriatic 79 
plaques present a dysbiosis from commensal colonisation (e.g. Staphylococcus epidermis) to 80 
opportunistic colonisation (e.g. S. aureus) (Holland et al., 2009; Sanford and Gallo, 2013), 81 
suggesting that a microbiome shift and altered innate immune signalling patterns may 82 
contribute to the pathogenesis.  83 
Previously, we determined that peptidoglycan (PGN), a key component of the Gram-positive 84 
bacterial cell wall and potent inducer of the innate immune response, triggered ATP release 85 
from cells expressing KID mutations but not ‘non-KID’ mutations (Donnelly et al., 2012). This 86 
event subsequently triggered downstream signalling responses, enhancing release of 87 
Interleukin 6 (IL-6) that could be reduced by connexin-channel blockers. PGN also modified 88 
connexin expression and function in astrocytes, glial and endothelial cells (Ceelen et al., 2011; 89 
Esen et al., 2007; Retamal et al., 2007b). Toll-Like receptor 2 (TLR2) is a key receptor 90 
associated with triggering innate immune signalling cascades and a variety of studies have 91 
reported links between connexin-hemichannel activity and TLR2 signalling events (Ey et al., 92 
2009; Martin and Prince, 2008; Robertson et al., 2010). 93 
In the present work we have explored the impact of PGN on connexin and pannexin expression 94 
and function in HaCaT cells, a model keratinocyte cell line that can differentiate and stratify in 95 
a manner similar to normal epidermis (Boukamp et al., 1988). We report that PGN induces 96 
CX26, TLR2 and IL-6 expression and siRNA-knockdown (KD) strategies indicate that both 97 
IL-6 and CX26 are targets of TLR2 activation. Furthermore, CX43 and CX26 expression are 98 
linked with activation of connexin-hemichannel activity and induction of the innate immune 99 
response, highlighting the potential of connexin-related therapeutic strategies to help regulate 100 






2. MATERIALS AND METHODS 105 
2.1. Cell culture 106 
The human keratinocyte cell line HaCaT (Cell Line Service (Boukamp et al., 1988) was 107 
maintained in Dulbecco's Modified Eagle's Medium high glucose (4.5 g/L) without L-108 
glutamine (DMEM, SLS, Newhouse, UK) supplemented with 10 % (v/v) Foetal Bovine Serum 109 
(FBS, Lonza), 50 U/mL penicillin/streptomycin (SLS, Newhouse, UK) and 2 mM L-glutamine 110 
(SLS, Newhouse, UK) (cDMEM). Cells were cultured in a 37 ºC humidified incubator in an 111 
atmosphere of 5 % CO2. Under these conditions, HaCaT cells do not stratify but maintain a 112 
phenotype similar to that of epidermal basal keratinocytes. Cells were seeded at appropriate 113 
densities into 24-well plates for ATP assay (approximately 7.5x104 cells per well), onto 16 114 
mm2 glass coverslips in a 12-well plate for immunostaining (approximately 1x105 cells per 115 
well) and into 6-well plates for ELISA, protein and RNA extraction (approximately 0.5x106 116 
cells per well).  117 
2.2. SiRNA Knock-down 118 
Cells were transfected with appropriate siRNA duplex sequences targeted to CX26, CX43, 119 
TLR2 or PANX1 (5 nM) (TriFECTa®RNAi Kit, IDT, Leuven, Belgium) or a fluorescently 120 
labelled scrambled siRNA transfection control duplex: TYE 563™ (IDT, Leuven, Belgium), 121 
using Lipofectamine 3000 according to the manufacturer’s instructions (Invitrogen, Paisley, 122 
UK). All assays were performed 24 hours (h) post-transfection.  123 
2.3. Cell treatments and challenges 124 
HaCaT cells were treated with serum free medium without antibiotics and supplemented with 125 
L-glutamine (sfDMEM) in the presence or absence of the connexin channel blockers 50 µM 126 
carbenoxolone (CBX, Sigma Aldrich, Irvine, UK), Gap26 100nM or Gap27 100nM (Zealand 127 
Pharma, Glostrup, Denmark) (Faniku et al., 2018; Wright et al., 2009) for 1 h prior to challenge 128 
with 10 μg/mL PGN isolated from S. aureus (Sigma-Aldrich, Irvine, UK) for 15 minutes (min), 129 
1, 3, 6 or 24 h as described previously (Donnelly et al., 2012). Connexins blockers were in the 130 
medium throughout the PGN challenge. HaCaT cells were exposed also to BAY11-7082 131 
(Invivogen, Toulouse, France), an inhibitor of NF-kB, at 10 µM for 24 h (Jiang et al. 2017), 132 
suramin (Tocris, Abingdon, UK), an antagonist of P2Y receptors, at 100 µM for 1h (Lee et al. 133 
2001) and A438079 (Tocris, Abingdon, UK), an antagonist of P2X7, at 5 µM for 1h (Mankus 134 
et al. 2011) in sfDMEM.  135 
2.4. Reverse-transcription and real-time PCR 136 
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RNA was isolated using Nucleospin RNA 11Kit (Bioline, London, UK), DNAse treatment 137 
with Ambion DNA-free™ kit (Thermofisher, Paisley, UK) and cDNA synthesised with the M-138 
MLV reverse transcription kit (Promega, Southampton, UK). Taqman real time PCR quantified 139 
the expression of CX26, CX43, GAPDH, PANX1, Ki67, IL-6 and IL-8 (Primer Design, 140 
Southampton, UK, and Sigma-Aldrich, Irvine, Scotland, proprietary validated). The PCR 141 
mixture contained 1 x Precision PLUS RT-qPCR MasterMix (Primer Design, Southampton, 142 
UK), 0.4 µM of each primer and probe, 0.25 ng/µL cDNA and RNase free H2O adjusted to a 143 
final volume to 10 µL. RT-qPCR was performed in a ViiA™ 7 Real-Time PCR System 144 
(Thermo Fisher, Paisley, UK) under the following cycling conditions: 95 °C for 15 min, 145 
followed by 40 cycles of 95 °C for 15 seconds (s) and 60 °C for 30 s. mRNA levels were 146 
obtained from the value of threshold cycle (Ct) for each specific gene and normalised against 147 
the Ct of GAPDH (ΔΔCt method (Livak, 2001). Gene fold changes ≥±2 were considered 148 
biologically significant (Dalman, 2012). 149 
2.5. Western blot analysis and immunohistochemistry 150 
Cells were harvested in 100 μl ice-cold RIPA lysis buffer (Santa Cruz, Heidelberg, Germany) 151 
per well. Total protein (50-100 μg depending on the  protein) was separated on 10-12 % (w/v) 152 
SDS polyacrylamide gels and transferred to a nitrocellulose membrane (GE Healthcare Ltd, 153 
Amersham, UK) using a TE22 Mighty Small Transfer Tank (Hoefer, Holliston, USA) for 3 h 154 
at 100 V. Membranes were blocked with 5 % (w/v) skimmed milk in TBS-T (200 mM Tris, 155 
1.5 mM NaCl, 0.1 % (v/v) Tween 20) and probed with primary antibodies: Rabbit polyclonal 156 
anti-CX26 1:100 (51-2800, Invitrogen, Paisley, UK), Rabbit polyclonal anti-CX43 1:1000 157 
(Ab-367, Sigma-Aldrich, Irvine, UK), Rabbit polyclonal anti-PANX1 1:1000 (HPA016930, 158 
Sigma-Aldrich, Irvine, UK) or Mouse monoclonal anti-GAPDH 1:1000 (sc-32233, Santa Cruz, 159 
Heidelberg, Germany ) respectively, at  4°C overnight. Secondary antibodies IRDye® 800CW 160 
Goat anti-Rabbit IgG (H + L) and IRDye® 680RD Goat anti-Mouse IgG diluted 1:10,000 (LI-161 
COR, Cambridge, UK) were used. The fluorescence was visualised by digital imaging using 162 
an Odyssey FC Dual Mode Imaging system (LI-COR, Cambridge, UK) and densitometry 163 
values were obtained using Image Studio software. Band densities were normalised to GAPDH 164 
protein density values (Taylor et al., 2013). 165 
For immunohistochemistry cells were fixed in ice-cold methanol for 3 min at -20 ˚C, 166 
permeabilised by incubation with phosphate-buffered saline (PBS, SLS, Newhouse, UK) and 167 
0.1 % (v/v) Triton X-100 for 30 min at room temperature and blocked with 5 % (w/v) milk-168 
PBS for 30 min. The incubation with the primary antibody was overnight at 4 ˚C, Rabbit 169 
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polyclonal anti-CX43 diluted 1:100 (Leithe and Rivedal, 2004), Mouse monoclonal anti-CX26 170 
diluted 1:50 (13-8100, Invitrogen, Paisley, UK) and anti-PANX1 diluted 1:100 (HPA016930, 171 
Sigma-Aldrich, Irvine, UK). The secondary antibody was Goat anti-rabbit conjugated to 172 
Alexa594 or Alexa488 or Goat anti-mouse conjugated to Alexa488 or Alexa594 (Sigma-173 
Aldrich, Irvine, UK). Nuclei were stained with DAPI (2.5 μg/mL) (Sigma-Aldrich, Irvine, UK). 174 
Slides were viewed on a Zeiss LSM 800 confocal microscope (Carl Zeiss Microscopy GmbH, 175 
Jena, Germany) enabling visualisation of Alexa488, Alexa594 and DAPI staining. Protein 176 
expression levels were semi-quantified by calculating the mean fold change in pixel intensity 177 
of treated versus control cells using Zen 2. Blue edition software (Carl Zeiss Microscopy 178 
GmbH, Jena, Germany). 179 
2.6. Hemichannel activity assessment: ATP release assay 180 
In experiments where connexin inhibitors were employed, cells were pre-incubated with them 181 
for 1 h. Cells were then stimulated with 10 µg/ml PGN or calcium-free PBS (SLS, Newhouse, 182 
UK) for 15 min. Following stimulation, 25 μL of each sample was transferred to a white, 183 
opaque 96-well plate. Into each well 25 μL of 1:10 ATP assay mix: ATP assay mix dilution 184 
buffer (Adenosine 5′-triphosphate (ATP) Bioluminescent Assay Kit, Sigma-Aldrich, Irvine, 185 
UK) was loaded. Luminescence was recorded following a 5s orbital mix using a FLOUstar 186 
OPTIMA (BMG Labtech, Ortenberg, Germany) luminometer. ATP concentration in each 187 
sample was calculated from a standard curve for all experiments (Faniku et al., 2018). Data is 188 
represented as the fold change in ATP concentration in the supernatant between control and 189 
treated cells. 190 
2.7. ELISA 191 
Culture supernatants were harvested following the treatments and assayed for IL-6 levels by 192 
ELISA assay (Quantikine® ELISA, RnDSystems, Abingdon, UK) according to the 193 
manufacturer’s instructions. Absorbance was recorded at 450 nm and corrected to 570 nm 194 
using a FLOUstar OPTIMA plate reader (BMG Labtech, Ortenberg, Germany). The IL-6 195 
concentration was calculated from a standard curve for all experiments. Data is represented as 196 
the fold change in IL-6 concentration in the supernatant between control and treated cells.  197 
2.8. Statistical analysis 198 
Experiments were performed in triplicate per setting and repeated on at least three separate 199 
occasions. All values indicate the mean ± SEM; the number of independent experiments is 200 
denoted by n. Data were compiled and analysed in GraphPad Prism 6 (GraphPad software, La 201 
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Jolla, San Diego, CA, USA). Statistical analysis was performed using Student’s unpaired t-test 202 
or one-way ANOVA followed by Dunnett’s as appropriate for data sets, detailed in figure 203 
legends. Statistical significance inferred at *P < 0.05; **P < 0.01; ***P < 0.001. 204 
 205 
3. RESULTS 206 
3.1. PGN from S. aureus induces changes in IL6, IL8, CX26 and TLR2 gene expression in 207 
HaCaT cells 208 
To determine the impact of PGN isolated from S. aureus on gene expression profiles HaCaT 209 
cells were exposed to PGN for periods of 15 min to 24 h, followed by mRNA extraction and 210 
real time PCR analysis. IL-6 and IL-8 transcripts were examined as indicators of activation of 211 
pro-inflammatory signalling by PGN exposure. PGN treatment induced a potent up-regulation 212 
of both interleukin gene transcripts within 1-3 h of challenge (>50-fold increase, ***p<0.001), 213 
which gradually reduced, with expression levels still >5-fold above basal levels at 24 h (Fig 214 
1A, B). A transient increase in CX26 transcripts, peaking at 6 h, where expression was >10-215 
fold above basal levels, and returning to basal levels after 24 h of exposure occurred (Fig 1C, 216 
***p<0.001). By contrast, CX43 transcripts were not induced (≤2-fold) above the threshold 217 
considered biologically significant (Dalman, 2012), during the 24 h PGN challenge (Fig 1D). 218 
Inflammatory skin diseases are often characterised by hyperproliferation, for which Ki67 is a 219 
common cell proliferation marker (Li et al., 2015). The level of Ki67 gene expression was 220 
unchanged during 24 h PGN exposure, suggesting keratinocyte proliferation was not evoked 221 
by treatment with PGN (Fig 1E). TLR2 is a potential receptor that recognises PGN, triggering 222 
pro-inflammatory signalling events. TLR2 transcripts increased during 3 to 24 h of PGN 223 
challenge, peaking 6 h post exposure, confirming that TLR2 is part of the pro-inflammatory 224 
response enhanced by PGN in HaCaT cells (Fig 1F, *p<0.05). 225 
3.2. PGN from S. aureus differentially regulates CX43 and CX26 protein levels in 226 
keratinocytes 227 
Immunostaining showed an increase in CX26 expression following 6-24 h exposure to PGN 228 
with increased protein distributed throughout the cytoplasm and at points of cell to cell contact 229 
on the plasma membrane (Fig 2 Ai-iii, supplementary Fig 1A, p<0.05). Immunostaining also 230 
confirmed the presence of CX43 at points of cell contact under normal conditions with a 231 
reduction of CX43 following 24 h PGN exposure evident (Fig 2Bi-iii). 232 
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An increase in CX26 protein expression following 3 h treatment with PGN was detected by 233 
western blot analysis (Fig 2C), consistent with gene transcript data (Fig 1C). Transfection of 234 
the cells with siRNA targeted to CX26 prevented the PGN induced CX26 expression (Fig 2C 235 
KD lanes). By contrast, western blot analysis further determined that CX43 protein levels were 236 
reduced ~50% following 24 h exposure to PGN, particularly levels of non-phosphorylated 237 
CX43 (P0) (Fig 2D, supplementary Fig 1 B, p<0.005). 238 
3.3. CX26 and TLR2 siRNA knock-down and NF-kB blocking reduce PGN effects on IL6 239 
and CX26 gene expression 240 
To investigate the impact of CX26, CX43 and TLR2 on PGN induced responses these genes 241 
were knocked-down (KD) by delivery of siRNA targeted to CX26, CX43 or TLR2 respectively. 242 
The transfection efficiency of siRNA, determined by fluorescent microscopy analysis of the 243 
TYE 563TM scrambled siRNA control was ~90% (data not shown). Twenty-four hours post 244 
transfection with each siRNA, mRNA was harvested and subject to RT-qPCR analysis to 245 
determine efficiency of gene knock-down under basal conditions. CX26 expression was not 246 
reduced by siRNA-CX26, however this was predicted as under non-challenged conditions 247 
HaCaT cells express low levels of CX26 (Supplementary Fig 2A). Expression of CX43 was 248 
efficiently reduced following exposure to 5 nM siRNA targeted to CX43 (Supplementary Fig 249 
2B). TLR2 siRNA at 5 nM reduced TLR2 mRNA levels around 50%, under these basal 250 
conditions (supplementary Figure 1C).  251 
Subsequently, the cells were exposed to PGN for 3 h or 24 h prior to mRNA extraction and 252 
gene expression analysis. Following 3 h challenge with PGN IL-6 expression was enhanced by 253 
~30 fold over basal levels (*p<0.05), however KD of CX26 or TLR2 did not significantly 254 
influence this early event at the mRNA level (Fig 3A). By contrast, following 24 h exposure to 255 
PGN CX26-KD reduced the PGN-IL-6 evoked response by ~50% (+p<0.05) but CX43 and 256 
TLR2-KD had no significant effect (Fig 3B).  257 
Induction of CX26 transcripts by PGN was significantly reduced by both CX26-KD and TLR2-258 
KD following 3 h exposure to PGN (Fig 3C, +p<0.05), however this response was less at 259 
following 24 h exposure (Fig 3D).  260 
TLR2 expression evoked by PGN was reduced by up to 80% following TLR2-KD and 3 h PGN 261 
exposure (Fig 3E, +p<0.05). Following exposure to PGN for 24 h TLR2 remained at basal 262 
levels and it was not significantly affected by TLR2-KD (Fig 3F). 263 
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A key event in the TLR2 signalling pathway is the activation of NF-kB that acts as a 264 
transcription factor of the pro-inflammatory response. To determine the influence of NF-kB 265 
signalling on the PGN response HaCaT cells were pre-incubated with the NF-kB blocker BAY 266 
11-7082 for 24 h followed by 3 h PGN exposure. This pre-treatment reduced the IL-6 peak 267 
induced by PGN >50% and CX26 peak >30% (Fig 4A and B, +p<0.05 and ++p<0.005, 268 
respectively), but it did not change CX43 gene expression levels (Fig 4C). These data confirm 269 
that the TLR2-NF-kB axis is one of the pathways which directly regulates IL-6 and CX26 gene 270 
expression.  271 
3.4. PGN from S. aureus induces hemichannel activity and is regulated by CX26 and 272 
CX43 273 
Hemichannel opening was assessed by measuring ATP release in the presence or absence of 274 
connexin channel blockers. As a positive control cells were deprived of calcium for 15 min 275 
which promoted hemichannel opening and ATP accumulation in the supernatant (>25-fold 276 
increase, ***p<0.001). Pre-treatment with 50 µM CBX inhibited hemichannel opening 277 
induced by calcium deprivation, (Fig 5A, ++p<0.005). Acute exposure (15 min) of HaCaT cells 278 
to PGN also enhanced ATP release (*p<0.01), which was significantly reduced by co-279 
incubation with 100 nM Gap26 (Fig 5B, +p<0.05). ATP release induced by acute PGN 280 
exposure was also reduced by CX26- or CX43-KD (+p< 0.05). TLR2-KD also showed a 281 
reduction in the PGN-induced ATP release, however this trend was not statistically significant 282 
to the PGN induced response (Fig 5C).  283 
3.5. Release of IL-6 is reduced by CX channel blockers and TLR2-KD 284 
The release of IL-6 from HaCaT cells following PGN challenge was determined by ELISA 285 
assays. HaCaT cells accumulated IL-6 in the supernatant during 24 h exposure to PGN (Fig 286 
6A, ***p<0.001). Exposure to the Cx channel blockers 50 µM CBX or 100 nM Gap27 alone 287 
did not influence basal IL-6 levels (Fig 6B and C). However, co-treatment with PGN and CBX 288 
or GAP27 significantly reduced the level of IL-6 release compared to PGN alone (Fig 6B and 289 
C, +p<0.05 and ++p<0.005 respectively).  290 
The IL-6 concentration in the supernatant was not affected by CX26, CX43 or TLR2 KD under 291 
non-challenged conditions (black columns), although TLR2-KD reduced the PGN evoked IL-292 
6 response following 24 h (Fig 6D, +p<0.05). CX26-KD inhibited the IL-6 response following 293 
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PGN challenge in multiple experiments (Fig 6D, +p<0.05). By contrast CX43-KD had no 294 
influence on the IL-6-PGN evoked response.  295 
Finally, purinergic signalling blockers suramin (a general blocker) and A438079 (a P2X7R 296 
blocker) did not induce IL-6 accumulation in the supernatant in the absence of PGN. Pre-297 
incubation with these blockers for 1 h followed by PGN exposure for 24 hours exhibited a trend 298 
towards inhibition of the IL-6 response induced by PGN (Fig 6E). The data further suggests 299 
that purinergic signalling contributes to maintaining IL-6 release under PGN challenge.  300 
3.6. PANX1 does not play a role in the PGN induced pro-inflammatory response.  301 
PANX1 is increasingly shown to be associated with purinergic signalling and pro-302 
inflammatory mediated events (Crespo Yanguas et al., 2017). PANX1 gene expression was not 303 
modified by PGN exposure throughout the 24 h challenge (Supplementary Fig 3A). Western 304 
blot and immunostaining analysis revealed no significant change in PANX1 protein expression 305 
during 24 h PGN treatment, and its distribution within the plasma membrane remained 306 
unaltered (Supplementary Fig 3 B-C). 307 
Finally, to determine if PANX1 played a role in the PGN evoked response, ATP and IL-6 308 
release were studied following reduction of PANX1 expression by transfecting HaCaT cells 309 
with siRNA targeted to PANX1. This caused ~70% reduction in PANX1 transcripts at 5 nM 310 
(Supplementary Fig 4A, ***p<0.001). However, knock-down of PANX1 did not significantly 311 
change ATP release or IL-6 transcript levels (Supplementary Fig 4B and C). 312 
4. Discussion 313 
In the present work, we characterised connexin expression and activity during the pro-314 
inflammatory response in keratinocytes. CX26 was acutely up-regulated following PGN 315 
challenge when it was used to simulate a pro-inflammatory environment. We determined for 316 
the first time in keratinocytes that this up-regulation is closely linked to the TLR2 signalling 317 
pathway by showing that TLR2 knockdown reduced CX26 PGN-induction and Cx 318 
hemichannel activity. Inhibition of connexin-hemichannel signalling or a reduction in CX26 319 
expression decreased the pro-inflammatory response in keratinocytes, as represented by the 320 
IL6 response to PGN. By contrast our studies determined that PANX1 does not play a 321 
significant role in the induction of this early innate immune response in keratinocytes and that 322 
prolonged exposure to PGN reduces CX43 protein expression. The data correlates with current 323 
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literature supporting the concept that enhanced CX26 expression and function is associated 324 
with a range of epidermal and epithelial pathologies (Chanson et al., 2018). We propose that 325 
the altered connexin balance elicited following PGN challenge evokes acute and long-term 326 
responses within the epidermis thereby influencing epidermal integrity. A summary of events 327 
is presented in Figure 7. 328 
S. aureus is a Gram positive opportunistic pathogen of the skin and is associated with increased 329 
bacterial load in conditions such as psoriasis, atopic dermatitis, chronic non-healing wounds 330 
and KID syndrome (Sanford and Gallo, 2013). Upon infection with S. aureus, PGN within or 331 
released from the bacterial cell wall interacts with TLR2 receptors and triggers the innate 332 
immune response. This results in a signalling cascade that, through a first Ca2+ wave, ultimately 333 
activates NF-kB and its translocation to the nucleus where it acts as a transcription factor 334 
(Dunne and O'Neill, 2005). CX26 mRNA expression was activated within one hour of exposure 335 
to PGN, in a similar timescale to IL-6 and IL-8, suggesting similar regulation. Previous studies 336 
and promoter activity searches revealed that the CX26 human promoter contains a potential 337 
binding site for NF-kB at -142bp relative to the translation start site (TSS) suggesting it is under 338 
a similar control mechanism to IL-6 and IL-8 (Dreos et al., 2017). Treatment of the cells with 339 
BAY11-7082, an inhibitor of NF-kB, reduced the PGN-evoked IL-6 and CX26 response but 340 
had no effect on CX43 expression. The increase in CX26 gene expression was followed by an 341 
increase in CX26 protein expression, determined by western blot and immunofluorescence, 342 
within 3-6 h, with gene expression returning to basal levels by 24 h. It was noteworthy that 343 
neither CX43 nor PANX1 gene expression responded to PGN challenge at these timescales.  344 
Up-regulation of CX26 is associated with several pathological skin conditions and is believed 345 
to be associated with elevated levels of inflammation. A recent psoriatic plaque transcriptome 346 
analysis identified CX26 as one of the top 100 genes up-regulated (Li et al., 2014; Martin and 347 
van Steensel, 2015). The present data suggests that such up-regulation of CX26 expression 348 
throughout the epidermis may also result in enhanced hemichannel activity that might promote 349 
the defective differentiation of keratinocytes associated with psoriasis (Chanson et al., 2018). 350 
Observations in transgenic mice over-expressing CX26 in the suprabasal layer developed a 351 
hyperproliferative phenotype, similar to a number of epidermal human CX26 chanelopathies 352 
(Djalilian et al., 2006). An increase in CX26-hemichannel activity is related with inflammatory 353 
skin diseases as dominant mutations on the N-terminal tail or transmembrane-domain 2 evoke 354 
‘leaky’ CX26-hemichannels, which is associated with the inflammatory condition KID 355 
syndrome (OMIM# 148210) (Donnelly et al., 2012; Garcia et al., 2015). Furthermore, in 356 
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chronic non-healing wound margins CX26 and Cx30 expression are up-regulated and are 357 
proposed to contribute to the inflammatory and proliferative status of the wound (Sutcliffe et 358 
al., 2015).  359 
TLR2 is the prime receptor for PGN and is widely expressed in keratinocytes (Mempel et al., 360 
2003). PGN interaction with TLR2 activates signalling cascades that induce expression of 361 
inflammatory cytokines and chemokines (Dunne and O'Neill, 2005; Ey et al., 2009). In HaCaT 362 
cells, TLR2 gene expression was up-regulated by PGN exposure peaking after 6 h challenge. 363 
IL-6 and IL-8 were also acutely activated through the induction of the TLR2 signalling 364 
pathway. This was confirmed by siRNA inhibition of TLR2 expression that reduced both IL-6 365 
gene expression and release following PGN exposure. IL-6 gene expression and release after 366 
PGN challenge was also reduced by CX26 KD, however CX43KD did not influence the PGN 367 
evoked response. The data suggest that CX26 may be an intermediate in PGN stimulation of 368 
IL-6 expression, perhaps by communicating TLR2-Ca2+ fluxes which finally induce IL-6 369 
expression by NF-kB (Dunne and O'Neill, 2005; Ey et al., 2009). A similar mechanism of 370 
regulation between TLR2 and connexins was previously demonstrated in the airway epithelium 371 
where CX43-gap junctions were reported to be involved in the initial spread of TLR2-Ca2+ 372 
fluxes. The data from these studies strongly suggest that in the airway epithelium TLR2 373 
stimulation induces acute changes in CX43 phosphorylation status and thereby gap junction 374 
activity (Ey et al., 2009; Martin and Prince, 2008). 375 
There are a number of other examples reported in different tissues where TLR2 and connexin 376 
expression are linked. In endothelial cells the PGN-TLR2 axis regulated Cx43 expression and 377 
acutely evoked hemichannel activity (Robertson et al., 2010). TLR2 was also determined to 378 
modulate Cx43 synthesis and increase GJIC via CX43 during intestinal epithelial cell injury 379 
(Ey et al., 2009) and the PGN-TLR2 axis reduced Cx43 and Cx30 expression with an associated 380 
increase in CX26 expression in astrocytes (Esen et al., 2007). In the present work the link 381 
between TLR2 and CX26 in keratinocytes was confirmed by knocking-down TLR2 expression 382 
which consequently prevented the induction of CX26 gene expression following 3 h PGN 383 
challenge. 384 
The PGN induced IL-6 response was not totally reduced following TLR2 knock-down, 385 
suggesting that other pathways are also involved. A role of extracellular ATP, connexin-386 
hemichannels and purinergic receptors in inflammation and infectious disease has recently 387 
been recognized (Burnstock et al., 2012; Diezmos et al., 2016). ATP, a second messenger and 388 
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main purinergic messenger, is released into the extracellular space in apoptosis and 389 
inflammation by exocytosis, transporters and connexin-hemichannels (Eugenin, 2014). 390 
Previous studies in endothelial cells and HeLa cells expressing CX43 determined that PGN can 391 
acutely promote hemichannel opening (Robertson et al., 2010). In HaCaT cells transfected to 392 
express KID syndrome mutations PGN isolated from S. aureus, but not the skin commensal S. 393 
epidermidis, was also able to trigger hemichannel activity (Donnelly et al., 2012). Other 394 
bacterial cell wall components including lipopolysaccharide (LPS) from Gram negative 395 
bacterial cell walls, also augments astrocyte and microglial hemichannel opening and is 396 
reported to decrease gap junctional communication in liver and heart, (Eugenin, 2014; Lapato 397 
and Tiwari-Woodruff, 2018; Retamal et al., 2007a). The hemichannel opening triggered 15 398 
min following exposure to PGN provides substantial evidence that connexin-hemichannel 399 
activity is involved in regulating the pro-inflammatory events evoked by PGN. In addition, 400 
ATP release was blocked by the general Cx-channel blocker CBX and connexin mimetic 401 
peptides Gap26 and Gap27. Connexin mimetic peptides (CMPs) are specific short sequences 402 
copied from connexin specific domains: Gap26 mimics the sequence of the extracellular loop 403 
1 and Gap27 the extracellular loop 2 of CX43. Both have been widely used to inhibit Cx 404 
mediated signalling events in diverse tissue networks (Willebrords et al., 2017). We have 405 
recently reported that Gap27 is effective in inhibiting ATP release from keratinocytes at 406 
concentrations of 100 nM, where it promotes keratinocyte migration with limited effect on 407 
proliferation (Faniku et al., 2018). Gap27 is reported to be specific for CX43 and Cx37 by 408 
several groups (Martin et al., 2005). This suggests that CX43 signalling plays a role in the acute 409 
term response elicited in keratinocytes following PGN challenge. Gap26 has a broader 410 
connexin specificity, and is also reported to be a more effective hemichannel inhibitor that 411 
Gap27, which may explain the slightly greater reduction in ATP release observed following 412 
PGN challenge (Desplantez et al., 2012; Wright et al., 2009). In cell migration studies 413 
previously performed in keratinocytes and fibroblasts, Gap26 was also slightly more efficient 414 
than Gap27 in keratinocytes which was attributed to the broader inhibitory capacity of this 415 
peptide (Wright et al., 2009). Whether the acute ATP release triggered within 15 min exposure 416 
to PGN is due to CX43 or CX26-hemichannels in keratinocytes is difficult to determine without 417 
highly selective CX26-hemichannel blockers; nevertheless, CX26 and CX43 knock-down 418 
reduced the ATP-peak induced by PGN, which confirms that both connexins are involved in 419 
this response. 420 
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Keratinocytes are reported to release ATP in a critical gradient dependent manner reflecting 421 
the differentiation status of the cells, with connexin signaling reported to play a role in the 422 
upper stratified layers, where CX26 tends to be spatially expressed (Tsutsumi et al., 2009). 423 
Most Cx-hemichannels are closed under ‘standard’ conditions, however CX26-hemichannels 424 
are an exception and human and sheep CX26 hemichannels are reported to form open voltage-425 
gated hemichannels under resting conditions (Gonzalez et al., 2006). The fact that following 426 
pro-inflammatory challenge CX26 expression is so dramatically upregulated suggests that the 427 
CX26 hemichannels produce an excessive release of ATP, which activates excitatory 428 
purinergic receptors of neighbouring cells. Thus overexpression of CX26 will alter basal ATP 429 
release levels and impact on pro-inflammatory events and differentiation programmes. Indeed, 430 
the present data further determined that the enhanced levels of CX26 and hemichannel activity 431 
within keratinocytes are linked with the trigger of inflammation because reduction of CX26 432 
expression and inhibition of hemichannel activity by using connexin-channel blockers 433 
dramatically decreased PGN-induced IL-6 expression. By contrast siRNA targeted to CX43 434 
had limited effect. 435 
Although an increase in CX43 expression was reported in endothelial cells following PGN 436 
challenge no changes in CX43 gene expression in keratinocytes was observed during PGN 437 
exposure. In endothelial cells Cx43 gene expression was increased 6 h following PGN 438 
challenge, but no overall decrease in Cx43 was observed following 24 h exposure (Robertson 439 
et al., 2010). By contrast in the present study in keratinocytes a small increase in CX43 gene 440 
expression was observed 15 min following PGN exposure but this was not above the two-fold 441 
increase and therefore not significant. Instead, immunofluorescence and western blot analysis 442 
determined an overall decrease in CX43 protein expression during the 24 h PGN exposure 443 
suggesting targeted degradation of the protein and this warrants further investigation.  444 
The mimetic peptide Gap27 targeting CX43 reduced IL-6 release in HaCaT cells, although not 445 
to the same extent as the generic channel blocker CBX, suggesting that other channels are 446 
involved in regulating these signalling pathways. Given the identification of a significant role 447 
for CX26 in the pro-inflammatory events we propose that initial localized events, triggered by 448 
PGN/TLR2 interactions contribute to the ‘acute’ innate immune trigger. As this trigger also 449 
results in enhancing CX26 levels we propose that the longer term responses are attributed to 450 
CX26 channel activity, particularly in chronically inflamed epidermal tissue where the 451 
expression of CX26 is exacerbated. A role for connexin signaling in chronic inflammation is 452 
receiving increased attention in diverse tissue networks (Kim et al., 2016; Willebrords et al., 453 
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2016). A range of peptides targeting CX43 clearly reduce inflammation and scarring in various 454 
systems including the skin and the cornea (Willebrords et al., 2017). The success of such 455 
peptides in translational research is highlighted by the Phase 3 clinical trial status for chronic 456 
non-healing wounds of ACT-1 (https://firststringresearch.com/ ) and on-going clinical reports 457 
by Ocunexus (https://ocunexus.com/ ).  458 
Pannexins, sister proteins to the connexins, sharing common topological membrane 459 
organization and channel formation with connexins are also increasingly associated with 460 
inflammatory mediated events and recruitment of the inflammasome. PANX1 has been shown 461 
to be involved in ATP release driving inflammation by assisting in the activation of 462 
inflammasomes, the release of pro-inflammatory cytokines and the activation and migration of 463 
leukocytes (Crespo Yanguas et al., 2017). PANX1 and Panx3 are expressed in keratinocytes 464 
and are proposed to have a complementary role to the connexins (Celetti et al., 2010). In the 465 
present work PANX1 was clearly expressed at the plasma membrane in HaCaT cell. ATP 466 
release via PANX1, is known to act as a paracrine transmitter and activates P2 receptors, such 467 
as P2X7R, this is followed by activation of an inflammatory response in immune cells with 468 
subsequent release of cytokines.  However, the present data suggests that in keratinocytes 469 
PANX1 does not participate in the acute PGN/TLR2 pro-inflammatory response, as PANX1 470 
gene and protein expression levels were not modified following PGN exposure and siRNA 471 
targeted to PANX1 did not influence PGN evoked ATP or IL-6 release. By contrast inhibition 472 
of purinergic receptor signalling reduced the PGN-IL-6 evoked response, confirming an 473 
important role for purinergic signalling in the process. 474 
In conclusion, HaCaT cells provide a valuable model for investigating the role of connexins in 475 
the epidermal innate immune response. The time courses of mRNA induction of IL-6, TLR2 476 
and CX26 following PGN challenge and the effects of knocking down TLR2 and CX26 477 
indicate both IL6 and CX26 are targets of TLR2 activation in HaCaT cells. At the protein level, 478 
our data points towards a significant role for connexin channel function influencing IL6 release. 479 
However, the acute nature of this response suggests that it does not involve CX26 alone, but 480 
that another connexin, probably CX43 is involved.  As CX43 is decreased at later timepoints 481 
we propose that the overexpression of CX26 in chronically inflamed keratinocytes may 482 
contribute to the exacerbated release of ATP that consequently further stimulates purinergic 483 
signalling and sustained inflammation. The acute response, may also trigger CX43 484 
hemichannel activity, but unlike other tissues, in keratinocytes this evokes the internalization 485 
of CX43 into the cytoplasm and ultimately reduces CX43 protein expression. As CX26 does 486 
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not interact with the cytoskeleton allowing cell plasticity, we propose the exacerbated 487 
hemichannel activity will also remodel critical ATP-Ca2+ gradients within the epidermis and 488 
trigger altered proliferation and differentiation of keratinocytes. Thus a chronically inflamed 489 
epidermis has an altered connexin balance that influences epidermal integrity and highlights 490 
that both CX26 and CX43 are prime therapeutic targets for inflammatory skin disease. By 491 
contrast our data suggest that PANX1 does not participate in the pro-inflammatory response 492 
induced by S. aureus in keratinocytes. Future work is required to dissect these events further. 493 
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Figure Legends 659 
Figure 1: Changes in gene expression following PGN challenge. 660 
HaCaT cells were challenged with 10 µg/mL PGN for 15 min, 1, 3, 6 and 24 h prior to mRNA 661 
extraction and RT-PCR analysis to determine A) IL-6, B) IL-8, C) CX26, D) CX43, E) Ki67 662 
and F) TLR2 gene expression profiles. Results are expressed as the fold increase in target gene 663 
expression over the housekeeping gene GAPDH compared to non-challenged cells (n=4). 664 
Statistical analysis performed using one-way ANOVA and Dunnet’s multiple comparison test 665 
compared to control, *p<0.05, **p<0.005, ***p<0.001. Red dotted line indicates +2-fold 666 
increase threshold and blue dotted line indicates -2-fold reduction threshold. 667 
 668 
Figure 2: Cx26 and Cx43 protein expression following 3-24 h PGN exposure.  669 
Ai-iii) Cx26 representative immunostaining under control conditions and following 6-24 h 670 
PGN challenge. Bi-iii) Cx43 representative immunostaining under control conditions and 671 
following 6-24 h PGN challenge. Arrows indicate punctate connexin staining at the cell 672 
membrane. Bar = 10µm. C) Representative Cx26 western blot under control conditions and 673 
following 3 h PGN challenge. Note the absence of Cx26 in samples exposed to siRNA targeted 674 
to Cx26 (KD). D) CX43 representative blot under control conditions and following 6 and 24 h 675 
PGN exposure. Note the reduction in Cx43 at 24 h. GAPDH loading control. Representative 676 
blots of n=5.  677 
 678 
Figure 3: Gene expression following siRNA knock-down and 3-24 h PGN. 679 
HaCaT cells were transfected with siRNA targeted to Cx26, Cx43 and TLR2 24 h prior to 680 
challenge with PGN for 3 or 24 h in order to determine A, B) IL-6; C, D) Cx26; E, F) TLR2 681 
gene expression levels. Results are expressed as the fold change in target gene expression over 682 
the housekeeping gene GAPDH compared to cells transfected with scrambled siRNA control. 683 
N=3, statistical analysis performed using t-test compared to control, *p<0.05 and ***p<0.001 684 
and t-test compared to PGN treated +p<0.05. Red dotted line indicates +2-fold increase 685 
threshold and blue dotted line indicates -2-fold reduction threshold. 686 
 687 
Figure 4: Changes in gene expression following NF-kβ blocking and PGN challenge.  688 
HaCaT cells were pre-blocked with BAY 11-7082 for 24 h and challenged with PGN 3 h prior 689 
to mRNA extraction and RT-qPCR analysis to determine A) IL-6; B) CX26 and C) CX43 gene 690 
expression profiles. Results are expressed as the fold increase in target gene expression over 691 
the housekeeping gene GAPDH compared to non-challenged cells (n=3). Statistical analysis 692 
was performed using one-way ANOVA and Dunnet’s multiple comparison test to compare 693 
PGN treated to control, *p<0.05, ***p<0.001 and t-test to compare PGN challenged and BAY 694 
11-7082+PGN treated cells respectively, +p<0.05, ++P <0.005. Red dotted line indicates +2-695 
fold increase threshold and blue dotted line indicates -2-fold reduction threshold. 696 
 697 
Figure 5: ATP release following challenge of HaCaT cells with zero Calcium or PGN.  698 
HaCaT cells were subject to: A)15 min exposure to Ca2+ free conditions in the presence or 699 
absence of 50 µM CBX; B) PGN for 15 min in the presence or absence of 100nM Gap26 or 700 
Gap27; C) siRNA-KD of Cx26, Cx43 and TLR2 24 h prior to challenge with 15 min PGN; 701 
prior to harvesting media and ATP analysis. Results are expressed as the fold increase in ATP 702 
concentration in the media compared to control cells (n=6). Significant differences determined 703 
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using one-way ANOVA followed by Dunnet’s multiple comparison analysis. *p<0.05; 704 
***p<0.001 compared to non-challenged control and t-test +p<0.05; ++p<0.005 compared 705 
to challenged cells to pre-blocked or KD samples. 706 
 707 
Figure 6: IL-6 release in the presence or absence of PGN, Cx blockers and/or purinergic 708 
blockers. 709 
The media from HaCaT cells was harvested and IL-6 levels determined by ELISA. A) HaCaT 710 
cells were exposed to 15min-24h PGN challenge. B) They were pre-treated with CBX for 1h 711 
and/or challenged with PGN for 6h. C) They were pre-treated with Gap27 for 1h and/or 712 
challenged with PGN for 6h. D) HaCaT cells were transfected with siRNA targeted Cx26, Cx43 713 
and TLR2 24h prior to challenge with PGN for 24 h. E) HaCaT cells were pre-treated with 714 
Suramin or A438079 1 h and PGN for 24 h (n=3). Data is presented as fold change of IL-6 715 
concentration in the supernatant in treated cells over control. Significant differences 716 
determined using one-way ANOVA followed by Dunnet’s multiple comparison analysis 717 
*p<0.05, **p<0.005 and ***p<0.001 compared to non-challenged control and t-test +p<0.05 718 
and ++p<0.005 compared treated with blocker-PGN or KD-PGN to treated cells with PGN 719 
only. 720 
 721 
Figure 7: Schematic representation of the proposed pathway linking Cx channel function 722 
and innate immunity in keratinocytes.  723 
(1) PGN from S. aureus interacts with TLR2 and produces an acute pro-inflammatory response 724 
and triggers hemichannel activity, releasing ATP from the cell within 15 min of challenge. (2) 725 
It also triggers intracellular signalling pathways that induce expression of Cx26 and IL-6. (4). 726 
(5) Overexpression of Cx26 increases ATP release, which activates purinergic signalling. (6) 727 
Purinergic signalling triggers subsequent signalling cascades maintaining a longer pro-728 
inflammatory response. (7) The longer-term interaction between PGN and TLR2 also induces 729 
the relocation and potential degradation of Cx43. 730 
 731 
Supplementary Figures 732 
Supplementary Figure 1: Exposure to PGN has differential effects on Cx26 and Cx43 protein 733 
expression and spatial localisation. A: HaCaT cells were exposed to PGN for 6 or 24 h followed 734 
by fixation and immunocytochemical analysis using an antibody targeting Cx26 (green). 735 
Histogram A represents semi-quantitative pixel intensity levels of Cx26 staining compared to 736 
non-challenged control (n=5).  B: HaCaT cells were exposed to PGN for 6 and 24 h prior to 737 
harvesting protein and subject to SDS PAGE and Western blot analysis using an antibody 738 
targeted to Cx43. Histogram B represents Cx43 expression extracted from image density 739 
analysis (n=5). Significant differences determined using ANOVA and Dunnet’s multiple 740 
comparison compared with the control *p<0.05; **p <0.01. 741 
Supplementary Figure 2: siRNA dose response. 742 
HaCaT cell were transfected with siRNA at different concentrations 24 h prior to mRNA 743 
extraction and RT-qPCR analysis to determine A) Cx26, B) Cx43 and C) TLR2 gene 744 
expression profiles. Results are expressed as fold change in target gene expression over the 745 
housekeeping gene GAPDH compared to cells transfected with scrambled siRNA control. 746 
N=3, statistical analysis performed using one-way ANOVA and Dunnet’s multiple comparison 747 
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test compared to control, **p<0.005 and ***p<0.001. Blue dotted line indicates -2-fold 748 
reduction threshold. 749 
 750 
Supplementary Figure 3: Panx1 gene and protein expression under PGN challenge. 751 
HaCaT cells were treated with PGN for 15 min to 24 h. A) Panx1 mRNA levels. Results are 752 
expressed as the fold increase in target gene expression over the housekeeping gene GAPDH 753 
compared to non-challenged cells (n=3). Statistical analysis performed using one-way 754 
ANOVA and Dunnet’s multiple comparison compared treated to control, *p<0.005, 755 
***p<0.001. B) Panx1 protein expression analysed by western blot and representative blot. 756 
Results are expressed as the fold increase in treated over to non-challenged cells. n=5, statistical 757 
analysis performed using one-way ANOVA and Dunnet’s multiple comparison test compared 758 
to control. C) Panx1 representative immunostaining. Bar= 10µm 759 
 760 
Supplementary Figure 4: Effects of Panx1 on the PGN response. 761 
A) Panx1 mRNA levels following siRNA against Panx1 transfection. Results are expressed as 762 
the fold increase in target gene expression over the housekeeping gene GAPDH compared to 763 
non-challenged cells (n=3). Statistical analysis performed using one-way ANOVA and 764 
Dunnet’s multiple comparison compared treated to control, **p<0.005, ***p<0.001. Blue 765 
dotted line indicates -2-fold reduction threshold. B) Fold change in ATP concentration in the 766 
supernatant following 24 h Panx1-KD and/or 15 min PGN (n=9). C) Fold change in IL-6 767 
concentration in the supernatant following 24 h Panx1-KD and/or 24h PGN (n=3). Data 768 
represented as fold change of the concentration of ATP or IL-6 in the supernatant in treated 769 
cells compared to untreated cells. Statistical analysis was also performed using t-test to 770 
compare treated to control cells. 771 
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